SCHEMBL6202481

SCHEMBL6202481

OCC(O)C(O)c1cccc(Br)c1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.48
SLC6A4 P31645 5/20 0.48
SLC6A3 Q01959 4/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2D6 P10635 3/20 0.48
KCNH2 Q12809 1/20 0.48
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
SLC18A3 Q16572 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
GLS O94925 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5911692 0.83 CYP3A4 (0.47) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL5773097 0.83 CYP3A4 (0.47) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL6202479 0.83 IDO1 (0.39) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL4361162 0.83 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL5831467 0.80 SLC18A3 (0.44) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL30153478 0.80 SLC18A3 (0.44) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL8257633 0.80 SLC18A3 (0.44) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL17660051 0.80 SLC18A3 (0.44) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL1812811 0.78 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL7605334 0.78 IDO1 (0.47) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed